Journal article · 2026

Discovery of Potent, Selective DNMT1 PROTAC Degraders: Simultaneous Blockade of Catalytic and Non-Catalytic Functions for Liver Fibrosis Therapy

Xingping Su, Taixiong Xue, Xinlei Liu, Meng Sun, Hongyao Liu, Yuanmei Bai, Qun Wei, Liang Ouyang, Zhihao Liu, Tinghong Ye

Journal of Medicinal Chemistry, 69(20), 23387–23410 · Published 8 October 2026 · DOI 10.1021/acs.jmedchem.5c03556

View at the publisherCite this paper

In brief

“Discovery of Potent, Selective DNMT1 PROTAC Degraders: Simultaneous Blockade of Catalytic and Non-Catalytic Functions for Liver Fibrosis Therapy” is a 2026 journal article by Xingping Su and 9 co-authors, published in Journal of Medicinal Chemistry. OpenAlex counts 1 citations as of 17 November 2026, which puts it in the top 9% of works published in 2026 by citations. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
1
Most cited in
2026 (1)
Field-weighted impact
1.27
References
45
Authors
10

Abstract

Liver fibrosis is a progressive pathological condition driven by chronic hepatic injury and currently lacks effective therapies. DNA methyltransferase 1 (DNMT1) promotes fibrogenesis through both catalytic and non-catalytic mechanisms. To simultaneously target these dual functions, we designed and synthesized a series of DNMT1-targeting PROTAC degraders based on DC-517. Our optimization campaign culminated in compound B7… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Su, X., Xue, T., Liu, X., Sun, M., Liu, H., Bai, Y., Wei, Q., Ouyang, L., Liu, Z., & Ye, T. (2026). Discovery of Potent, Selective DNMT1 PROTAC Degraders: Simultaneous Blockade of Catalytic and Non-Catalytic Functions for Liver Fibrosis Therapy. Journal of Medicinal Chemistry, 69(20), 23387–23410. https://doi.org/10.1021/acs.jmedchem.5c03556

MLA 9

Su, Xingping, et al. “Discovery of Potent, Selective DNMT1 PROTAC Degraders: Simultaneous Blockade of Catalytic and Non-Catalytic Functions for Liver Fibrosis Therapy.” Journal of Medicinal Chemistry, vol. 69, no. 20, 2026, pp. 23387–23410. https://doi.org/10.1021/acs.jmedchem.5c03556.

Chicago

Su, Xingping, Taixiong Xue, Xinlei Liu, Meng Sun, Hongyao Liu, Yuanmei Bai, Qun Wei, Liang Ouyang, Zhihao Liu, and Tinghong Ye. 2026. “Discovery of Potent, Selective DNMT1 PROTAC Degraders: Simultaneous Blockade of Catalytic and Non-Catalytic Functions for Liver Fibrosis Therapy.” Journal of Medicinal Chemistry 69 (20): 23387–23410. https://doi.org/10.1021/acs.jmedchem.5c03556.

Harvard

Su, X. et al. (2026) ‘Discovery of Potent, Selective DNMT1 PROTAC Degraders: Simultaneous Blockade of Catalytic and Non-Catalytic Functions for Liver Fibrosis Therapy’, Journal of Medicinal Chemistry, 69(20), pp. 23387–23410. doi:10.1021/acs.jmedchem.5c03556.

IEEE

X. Su et al., “Discovery of Potent, Selective DNMT1 PROTAC Degraders: Simultaneous Blockade of Catalytic and Non-Catalytic Functions for Liver Fibrosis Therapy,” Journal of Medicinal Chemistry, vol. 69, no. 20, pp. 23387–23410, 2026, doi: 10.1021/acs.jmedchem.5c03556.

BibTeX

@article{su2026discovery,
  title     = {{Discovery of Potent, Selective DNMT1 PROTAC Degraders: Simultaneous Blockade of Catalytic and Non-Catalytic Functions for Liver Fibrosis Therapy}},
  author    = {Su, Xingping and Xue, Taixiong and Liu, Xinlei and Sun, Meng and Liu, Hongyao and Bai, Yuanmei and Wei, Qun and Ouyang, Liang and Liu, Zhihao and Ye, Tinghong},
  journal   = {Journal of Medicinal Chemistry},
  year      = {2026},
  volume    = {69},
  number    = {20},
  pages     = {23387--23410},
  doi       = {10.1021/acs.jmedchem.5c03556},
  url       = {https://doi.org/10.1021/acs.jmedchem.5c03556}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors

  • DNMT1
  • PROTAC degraders
  • liver fibrosis
  • DNA methyltransferases
  • ubiquitin-proteasome degradation
  • global DNA methylation
  • collagen deposition
  • liver function

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Su, X., Xue, T., Liu, X., Sun, M., Liu, H., Bai, Y., Wei, Q., Ouyang, L., Liu, Z., & Ye, T. (2026). Discovery of Potent, Selective DNMT1 PROTAC Degraders: Simultaneous Blockade of Catalytic and Non-Catalytic Functions for Liver Fibrosis Therapy. Journal of Medicinal Chemistry, 69(20), 23387–23410. https://doi.org/10.1021/acs.jmedchem.5c03556

How many times has this paper been cited?

1 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Xingping Su, Taixiong Xue, Xinlei Liu, Meng Sun, Hongyao Liu, Yuanmei Bai, Qun Wei, Liang Ouyang, Zhihao Liu, Tinghong Ye.

What is the DOI of this paper?

10.1021/acs.jmedchem.5c03556, permanently at https://doi.org/10.1021/acs.jmedchem.5c03556. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.